Physician profile
Tom S Floyd
NPI 1265637839
$11,821.64
in general payments reported to CMS, 2019-2025
55 companies · $2,066 in 2025
The $2,066 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $943 · 2021: $1,598 · 2022: $1,879 · 2023: $2,383 · 2024: $1,921 · 2025: $2,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,364 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,364.04 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,077.63 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $994.43 | 2019-2025 | Lithovue, Ams 700 Cxr Rte Kit, Ams 700 |
| Urogen Pharma, INC. | $976.82 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $945.61 | 2019-2024 | Myrbetriq, Xtandi |
| Endo Pharmaceuticals INC. | $646.45 | 2019-2024 | Xiaflex, Aveed |
| Medtronic, INC. | $547.76 | 2021-2025 | Interstim |
| Antares Pharma, INC. | $477.69 | 2019-2025 | Xyosted |
| Abbvie INC. | $462.06 | 2019-2025 | |
| Accord Healthcare, INC. | $440.48 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $404.34 | 2019-2024 | Provenge |
| Laborie Medical Technologies Corp. | $324.61 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $322.60 | 2024-2025 | Xiaflex, Aveed |
| Coloplast Corp | $297.10 | 2019-2025 | Titan |
| Urovant Sciences INC | $277.31 | 2021-2022 | |
| Myovant Sciences INC. | $243.46 | 2021-2022 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.